Intech Biopharm Corporation (TPEX: 6461)
30.65
+1.15 (3.90%)
Sep 11, 2024, 9:38 AM CST
Intech Biopharm Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 174.37 | 77.73 | 64.82 | 220.48 | 204.69 | 172.12 | Upgrade
|
Short-Term Investments | 255 | 520 | 310 | 115 | 100 | 105 | Upgrade
|
Cash & Short-Term Investments | 429.37 | 597.73 | 374.82 | 335.48 | 304.69 | 277.12 | Upgrade
|
Cash Growth | 28.35% | 59.47% | 11.73% | 10.11% | 9.95% | 115.90% | Upgrade
|
Accounts Receivable | 3.12 | 3.05 | 3.67 | 15.04 | 4.87 | 3.59 | Upgrade
|
Other Receivables | 9.2 | 8.7 | 7.94 | 7.94 | 7.78 | 9.06 | Upgrade
|
Receivables | 12.33 | 11.74 | 11.6 | 22.98 | 12.65 | 12.65 | Upgrade
|
Inventory | 52.2 | 41.53 | 51.82 | 59.87 | 56.97 | 44.42 | Upgrade
|
Prepaid Expenses | 52.13 | 43.62 | 40.7 | 33.74 | 35.46 | 26.04 | Upgrade
|
Other Current Assets | 0.16 | 0.41 | 0.13 | 4.26 | - | - | Upgrade
|
Total Current Assets | 546.19 | 695.02 | 479.06 | 456.33 | 409.77 | 360.22 | Upgrade
|
Property, Plant & Equipment | 1,893 | 1,900 | 2,009 | 2,090 | 2,178 | 2,204 | Upgrade
|
Other Intangible Assets | 4.37 | 4.88 | 4.8 | 4.62 | 4.75 | 4.95 | Upgrade
|
Long-Term Deferred Tax Assets | 24.77 | 24.77 | 24.77 | 24.77 | 24.77 | 24.77 | Upgrade
|
Other Long-Term Assets | 88.43 | 86.15 | 33.17 | 26.26 | 4.31 | 12.15 | Upgrade
|
Total Assets | 2,557 | 2,711 | 2,551 | 2,602 | 2,621 | 2,606 | Upgrade
|
Accounts Payable | 12.25 | 0.31 | 1.33 | 2.4 | 1.02 | 0.39 | Upgrade
|
Accrued Expenses | 18.1 | 19.24 | 23.71 | 20.82 | 19.56 | 18.36 | Upgrade
|
Short-Term Debt | - | - | - | - | 30 | - | Upgrade
|
Current Portion of Long-Term Debt | 254.07 | 464.65 | 265.26 | 211.66 | 12.89 | 99.35 | Upgrade
|
Current Unearned Revenue | 78.31 | 78.54 | 78.31 | 78.99 | 81.21 | 81.38 | Upgrade
|
Other Current Liabilities | 5.2 | 5.99 | 5.23 | 9.35 | 9.86 | 7.51 | Upgrade
|
Total Current Liabilities | 367.92 | 568.73 | 373.82 | 323.22 | 154.52 | 206.99 | Upgrade
|
Long-Term Debt | 1,180 | 970.41 | 1,143 | 940.77 | 1,138 | 829.63 | Upgrade
|
Long-Term Unearned Revenue | 2.35 | 2.35 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 1.72 | 1.74 | 1.54 | - | - | - | Upgrade
|
Total Liabilities | 1,552 | 1,543 | 1,519 | 1,264 | 1,293 | 1,037 | Upgrade
|
Common Stock | 1,374 | 1,374 | 1,170 | 1,163 | 1,007 | 1,005 | Upgrade
|
Additional Paid-In Capital | 9.83 | 286.16 | 195.15 | 481.32 | 574.58 | 877.29 | Upgrade
|
Retained Earnings | -379.07 | -488.08 | -327.88 | -301.76 | -250.37 | -311.42 | Upgrade
|
Comprensive Income & Other | -0.02 | -4.32 | -5.13 | -4.72 | -2.7 | -1.78 | Upgrade
|
Shareholders' Equity | 1,005 | 1,168 | 1,032 | 1,338 | 1,329 | 1,569 | Upgrade
|
Total Liabilities & Equity | 2,557 | 2,711 | 2,551 | 2,602 | 2,621 | 2,606 | Upgrade
|
Total Debt | 1,434 | 1,435 | 1,409 | 1,152 | 1,181 | 928.99 | Upgrade
|
Net Cash (Debt) | -1,005 | -837.33 | -1,034 | -816.94 | -876.4 | -651.87 | Upgrade
|
Net Cash Per Share | -7.69 | -6.95 | -8.90 | -8.03 | -8.74 | -7.99 | Upgrade
|
Filing Date Shares Outstanding | 137.41 | 137.41 | 116.96 | 116.28 | 100.73 | 100.49 | Upgrade
|
Total Common Shares Outstanding | 137.41 | 137.41 | 116.96 | 116.28 | 100.73 | 100.49 | Upgrade
|
Working Capital | 178.26 | 126.3 | 105.24 | 133.11 | 255.25 | 153.23 | Upgrade
|
Book Value Per Share | 7.31 | 8.50 | 8.82 | 11.50 | 13.19 | 15.61 | Upgrade
|
Tangible Book Value | 1,000 | 1,163 | 1,027 | 1,333 | 1,324 | 1,564 | Upgrade
|
Tangible Book Value Per Share | 7.28 | 8.46 | 8.78 | 11.46 | 13.14 | 15.56 | Upgrade
|
Land | 919.87 | 919.87 | 950.72 | 950.72 | 950.72 | 950.72 | Upgrade
|
Buildings | 790.42 | 790.24 | 798.32 | 810.2 | 809.13 | 769.28 | Upgrade
|
Machinery | 692.15 | 657.12 | 645.9 | 633.52 | 616.6 | 597.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.